Baldwin Wealth Partners LLC MA Has $8.49 Million Stock Position in Waters Corporation $WAT

Baldwin Wealth Partners LLC MA trimmed its position in Waters Corporation (NYSE:WAT) by 4.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 24,332 shares of the medical instruments supplier’s stock after selling 1,181 shares during the quarter. Baldwin Wealth Partners LLC MA’s holdings in Waters were worth $8,493,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in WAT. Olde Wealth Management LLC acquired a new position in shares of Waters in the first quarter worth about $25,000. Zions Bancorporation National Association UT purchased a new stake in shares of Waters in the first quarter worth approximately $28,000. IFP Advisors Inc lifted its position in shares of Waters by 118.9% in the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock worth $30,000 after purchasing an additional 44 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Waters in the first quarter worth approximately $41,000. Finally, Steph & Co. purchased a new stake in shares of Waters in the second quarter worth approximately $73,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on WAT. JPMorgan Chase & Co. increased their price target on shares of Waters from $300.00 to $325.00 and gave the stock a “neutral” rating in a research report on Thursday. Rothschild & Co Redburn began coverage on shares of Waters in a research report on Wednesday. They issued a “buy” rating and a $390.00 price target for the company. Redburn Partners set a $390.00 price target on shares of Waters in a research report on Wednesday. Jefferies Financial Group set a $385.00 price target on shares of Waters and gave the stock a “buy” rating in a research report on Monday, August 4th. Finally, Wall Street Zen lowered shares of Waters from a “buy” rating to a “hold” rating in a research report on Saturday, July 26th. Two analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $377.56.

Waters Price Performance

Shares of WAT opened at $330.48 on Friday. The firm has a market cap of $19.67 billion, a PE ratio of 29.80, a PEG ratio of 3.05 and a beta of 1.04. The firm’s 50 day moving average price is $299.15 and its 200 day moving average price is $324.44. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $423.56.

Waters (NYSE:WAT) last issued its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, beating the consensus estimate of $2.93 by $0.02. The firm had revenue of $771.33 million for the quarter, compared to analyst estimates of $745.96 million. Waters had a net margin of 21.71% and a return on equity of 38.60%. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter last year, the firm earned $2.63 earnings per share. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. As a group, research analysts expect that Waters Corporation will post 12.86 EPS for the current fiscal year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.